期刊
NUCLEAR MEDICINE AND BIOLOGY
卷 31, 期 4, 页码 419-423出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.nucmedbio.2004.01.002
关键词
PET; p53; proliferation; FLT
资金
- NCI NIH HHS [P01 CA042045, CA34570, CA42045] Funding Source: Medline
The use of thymidine (TdR) and thymidine analogs Such as 3'-deoxy-3'-fluorothymidine (FLT) as positron emission tomography (PET)-based tracers of tumor proliferation rate is based on the hypothesis that measurement of uptake of these nucleosides, a function primarily of thymidine kinase-1 (TK1) activity, provides an accurate measure of cell proliferation in tumors. Tumor growth is influenced by many factors including the oxygen concentration within tumors and whether tumor cells have been exposed to cytotoxic therapies. The p53 gene plays an important role in regulating growth under both of these conditions. The goal of this study was to investigate the influence of p53 activation on cell growth, TK1 activity, and FLT uptake. To accomplish this, TK1 activity, S phase fraction, and the uptake of FLT were determined in plateau-phase and exponentially growing cultures of an isogenic pair of human tumor cell lines in which p53 expression was normal or inactivated by human papilloma virus type 16 E6 expression. Ionizing radiation exposure was used to Stimulate p53 activity and to induce alterations in cell cycle progression. We found that exposure of cells to ionizing radiation induced dose-dependent changes in cell cycle progression in both cell lines. The relationship between S phase percentage, TK1 activity, and FLT uptake were essentially unchanged in the p53-normal cell line. In contrast, TK1 activity and FLT uptake remained high in the p53-deficient variant even when S phase percentage was low due to a p53-dependent G2 arrest. We Conclude that a functional p53 response is required to maintain the normal relationship between TK1 activity and S phase percentage following radiation exposure. (C) 2004 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据